Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
519
archived clinical trials in
Bronchitis

Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated:  11/24/2015
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated: 11/24/2015
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated:  11/24/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated: 11/24/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated:  11/24/2015
Ohio State University
mi
from
Columbus, OH
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated: 11/24/2015
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated:  11/24/2015
Vanderbilt University
mi
from
Nashville, TN
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated: 11/24/2015
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated:  11/24/2015
Fred Hutchinson Cancer Research Center - Seattle Cancer Care Alliance
mi
from
Seattle, WA
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated: 11/24/2015
Fred Hutchinson Cancer Research Center - Seattle Cancer Care Alliance
mi
from
Seattle, WA
Click here to add this to my saved trials
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated:  11/24/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated: 11/24/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated:  11/24/2015
Mayo Clinic
mi
from
Scottsdale, AZ
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated: 11/24/2015
Mayo Clinic
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated:  11/24/2015
H. Lee Moffitt Cancer Center
mi
from
Tampa, FL
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated: 11/24/2015
H. Lee Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated:  11/24/2015
Washington University, St. Louis
mi
from
St. Louis, MO
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated: 11/24/2015
Washington University, St. Louis
mi
from
St. Louis, MO
Click here to add this to my saved trials
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated:  11/24/2015
Weill-Cornell Medical College
mi
from
New York, NY
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Status: Enrolling
Updated: 11/24/2015
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Effects of Delayed Cord Clamping in Very Low Birth Weight Infants
Effects of Delayed Cord Clamping in Very Low Birth Weight (VLBW) Infants
Status: Enrolling
Updated:  11/27/2015
Women and Infants Hospital
mi
from
Providence, RI
Effects of Delayed Cord Clamping in Very Low Birth Weight Infants
Effects of Delayed Cord Clamping in Very Low Birth Weight (VLBW) Infants
Status: Enrolling
Updated: 11/27/2015
Women and Infants Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Innate Immune Response in COPD
Innate Immune Response in COPD
Status: Enrolling
Updated:  12/18/2015
VA Puget Sound Health Care System
mi
from
Seattle, WA
Innate Immune Response in COPD
Innate Immune Response in COPD
Status: Enrolling
Updated: 12/18/2015
VA Puget Sound Health Care System
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety Study of Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS)
Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation
Status: Enrolling
Updated:  12/22/2015
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Safety Study of Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS)
Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation
Status: Enrolling
Updated: 12/22/2015
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety Study of Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS)
Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation
Status: Enrolling
Updated:  12/22/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Safety Study of Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS)
Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation
Status: Enrolling
Updated: 12/22/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Exhaled Nitric Oxide Levels in Infants and Young Children Infected With RSV or Other Viral Infections
A Prospective Study Measuring Exhaled Nitric Oxide Levels in Infants and Young Children Admitted to the Hospital for Respiratory Syncytial Virus (RSV) or Other Viral Lower Respiratory Tract Infections
Status: Enrolling
Updated:  12/23/2015
Winthrop University Hospital
mi
from
Mineola, NY
Exhaled Nitric Oxide Levels in Infants and Young Children Infected With RSV or Other Viral Infections
A Prospective Study Measuring Exhaled Nitric Oxide Levels in Infants and Young Children Admitted to the Hospital for Respiratory Syncytial Virus (RSV) or Other Viral Lower Respiratory Tract Infections
Status: Enrolling
Updated: 12/23/2015
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
N-Acetylcysteine for Patients With COPD and Chronic Bronchitis
Effects of High-Dose N-Acetylcysteine on Respiratory Health Status in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis: A Randomized, Placebo-Controlled Trial-3
Status: Enrolling
Updated:  1/25/2016
Univ of Minnesota
mi
from
Minneapolis, MN
N-Acetylcysteine for Patients With COPD and Chronic Bronchitis
Effects of High-Dose N-Acetylcysteine on Respiratory Health Status in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis: A Randomized, Placebo-Controlled Trial-3
Status: Enrolling
Updated: 1/25/2016
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Status: Enrolling
Updated:  2/22/2016
University of Missouri Children's Hospital
mi
from
Columbia, MO
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Status: Enrolling
Updated: 2/22/2016
University of Missouri Children's Hospital
mi
from
Columbia, MO
Click here to add this to my saved trials
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Status: Enrolling
Updated:  2/22/2016
Children's Mercy Hospital
mi
from
Kansas City, MO
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Status: Enrolling
Updated: 2/22/2016
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Status: Enrolling
Updated:  2/22/2016
Hasbro Children's Hospital
mi
from
Providence, RI
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Status: Enrolling
Updated: 2/22/2016
Hasbro Children's Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Status: Enrolling
Updated:  2/22/2016
CHRISTUS Santa Rosa Children's Hospital
mi
from
San Antonio, TX
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Intermittent Versus Continuous Pulse Oximetry Monitoring of Infants Admitted for Bronchiolitis
Status: Enrolling
Updated: 2/22/2016
CHRISTUS Santa Rosa Children's Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated:  3/1/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated: 3/1/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated:  3/1/2016
North Shore‐LIJ Health System Laboratories
mi
from
Lake Success, NY
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated: 3/1/2016
North Shore‐LIJ Health System Laboratories
mi
from
Lake Success, NY
Click here to add this to my saved trials
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated:  3/1/2016
Scott & White Memorial Hospital
mi
from
Temple, TX
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated: 3/1/2016
Scott & White Memorial Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated:  3/1/2016
St. Joseph's Hospital
mi
from
Hamilton,
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
Status: Enrolling
Updated: 3/1/2016
St. Joseph's Hospital
mi
from
Hamilton,
Click here to add this to my saved trials
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
Status: Enrolling
Updated:  3/1/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
Status: Enrolling
Updated: 3/1/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
Status: Enrolling
Updated:  3/1/2016
North Shore‐LIJ Health System Laboratories
mi
from
Lake Success, NY
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
Status: Enrolling
Updated: 3/1/2016
North Shore‐LIJ Health System Laboratories
mi
from
Lake Success, NY
Click here to add this to my saved trials
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
Status: Enrolling
Updated:  3/1/2016
Baylor Scott & White Health
mi
from
Temple, TX
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients
Status: Enrolling
Updated: 3/1/2016
Baylor Scott & White Health
mi
from
Temple, TX
Click here to add this to my saved trials
Seattle-PAP Bubble Nasal CPAP and Work of Breathing
A Study to Evaluate the Efficacy of Seattle-PAP for the Respiratory Support of Premature Infants
Status: Enrolling
Updated:  4/12/2016
Texas Children's Hospital
mi
from
Houston, TX
Seattle-PAP Bubble Nasal CPAP and Work of Breathing
A Study to Evaluate the Efficacy of Seattle-PAP for the Respiratory Support of Premature Infants
Status: Enrolling
Updated: 4/12/2016
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Developing and Evaluating User-Designed Data Displays
Developing and Evaluating User-Designed Data Displays
Status: Enrolling
Updated:  7/25/2016
Cincinnati Children's Hospital Medical Center Burnet Campus
mi
from
Cincinnati, OH
Developing and Evaluating User-Designed Data Displays
Developing and Evaluating User-Designed Data Displays
Status: Enrolling
Updated: 7/25/2016
Cincinnati Children's Hospital Medical Center Burnet Campus
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia
Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia
Status: Enrolling
Updated:  8/18/2016
Riley Children's Hospital
mi
from
Indianapolis, IN
Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia
Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia
Status: Enrolling
Updated: 8/18/2016
Riley Children's Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia
Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia
Status: Enrolling
Updated:  8/18/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia
Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia
Status: Enrolling
Updated: 8/18/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation
Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation. Can We Help Diagnose Acute Rejection and Better Predict Bronchiolitis Obliterans?
Status: Enrolling
Updated:  8/18/2016
University of Chicago Medical Center
mi
from
Chicago, IL
Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation
Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation. Can We Help Diagnose Acute Rejection and Better Predict Bronchiolitis Obliterans?
Status: Enrolling
Updated: 8/18/2016
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Transplant Optimization Using Functional Imaging
Transplant Optimization Using Functional Imaging
Status: Enrolling
Updated:  3/28/2017
Columbia University Medical Center
mi
from
New York, NY
Transplant Optimization Using Functional Imaging
Transplant Optimization Using Functional Imaging
Status: Enrolling
Updated: 3/28/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Transplant Optimization Using Functional Imaging
Transplant Optimization Using Functional Imaging
Status: Enrolling
Updated:  3/28/2017
Hospital of the University of Pennsylvania
mi
from
Gibson, PA
Transplant Optimization Using Functional Imaging
Transplant Optimization Using Functional Imaging
Status: Enrolling
Updated: 3/28/2017
Hospital of the University of Pennsylvania
mi
from
Gibson, PA
Click here to add this to my saved trials
Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
Prematurity and Respiratory Outcome Program: Single Center Study of Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
Status: Enrolling
Updated:  5/2/2017
Women and Children's Hospital of Buffalo
mi
from
Buffalo, NY
Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
Prematurity and Respiratory Outcome Program: Single Center Study of Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
Status: Enrolling
Updated: 5/2/2017
Women and Children's Hospital of Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
Prematurity and Respiratory Outcome Program: Single Center Study of Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
Status: Enrolling
Updated:  5/2/2017
Univ of Rochester Medical Center
mi
from
Rochester, NY
Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
Prematurity and Respiratory Outcome Program: Single Center Study of Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
Status: Enrolling
Updated: 5/2/2017
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of Tobacco Smoke and Children With Respiratory Illnesses
Urine Cotinine in Children and Parental Behavior Modification: A Pilot Study
Status: Enrolling
Updated:  5/15/2017
The Barbara Bush Children's Hospital at Maine Medical Center
mi
from
Portland, ME
A Study of Tobacco Smoke and Children With Respiratory Illnesses
Urine Cotinine in Children and Parental Behavior Modification: A Pilot Study
Status: Enrolling
Updated: 5/15/2017
The Barbara Bush Children's Hospital at Maine Medical Center
mi
from
Portland, ME
Click here to add this to my saved trials
Sustained Effects of Hypertonic Saline on Mucociliary Clearance in Subjects With Chronic Bronchitis
Novel Therapies for Muco-Obstructive Lung Diseases: Sustained Effects of Hypertonic Saline on Mucociliary Clearance and Clinical Tolerability in Subjects With Chronic Bronchitis
Status: Enrolling
Updated:  6/22/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Sustained Effects of Hypertonic Saline on Mucociliary Clearance in Subjects With Chronic Bronchitis
Novel Therapies for Muco-Obstructive Lung Diseases: Sustained Effects of Hypertonic Saline on Mucociliary Clearance and Clinical Tolerability in Subjects With Chronic Bronchitis
Status: Enrolling
Updated: 6/22/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Novel Therapies for Muco-Obstructive Lung Diseases: Testing the Transnasal Pulmonary Delivery Device in COPD/CB Subjects
Novel Therapies for Muco-Obstructive Lung Diseases: A Study of Tolerability and MCC Effect of Hypertonic Saline Delivered Via the tPAD in Patients With Chronic Bronchitis
Status: Enrolling
Updated:  6/22/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Novel Therapies for Muco-Obstructive Lung Diseases: Testing the Transnasal Pulmonary Delivery Device in COPD/CB Subjects
Novel Therapies for Muco-Obstructive Lung Diseases: A Study of Tolerability and MCC Effect of Hypertonic Saline Delivered Via the tPAD in Patients With Chronic Bronchitis
Status: Enrolling
Updated: 6/22/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Heated High Flow Oxygen Use in Infants With Bronchiolitis and Hypoxia
Comparison of Heated Humidified High-flow Nasal Cannula (HHFNC) Versus Standard Nasal Cannula Oxygen Delivery on Respiratory Distress and Length of Stay in Infants With Bronchiolitis and Hypoxia
Status: Enrolling
Updated:  7/18/2017
Children's Hospitals and Clinics of Minnesota
mi
from
Minneapolis, MN
Heated High Flow Oxygen Use in Infants With Bronchiolitis and Hypoxia
Comparison of Heated Humidified High-flow Nasal Cannula (HHFNC) Versus Standard Nasal Cannula Oxygen Delivery on Respiratory Distress and Length of Stay in Infants With Bronchiolitis and Hypoxia
Status: Enrolling
Updated: 7/18/2017
Children's Hospitals and Clinics of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Status: Enrolling
Updated:  9/4/2017
Clinical Research Facility
mi
from
Peoria, AZ
Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Status: Enrolling
Updated: 9/4/2017
Clinical Research Facility
mi
from
Peoria, AZ
Click here to add this to my saved trials
Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Status: Enrolling
Updated:  9/4/2017
Clinical Research Facility
mi
from
Fountain Valley, CA
Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Status: Enrolling
Updated: 9/4/2017
Clinical Research Facility
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Status: Enrolling
Updated:  9/4/2017
Clinical Research Facility
mi
from
La Jolla, CA
Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Status: Enrolling
Updated: 9/4/2017
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Status: Enrolling
Updated:  9/4/2017
Clinical Research Facility
mi
from
Long Beach, CA
Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Status: Enrolling
Updated: 9/4/2017
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Status: Enrolling
Updated:  9/4/2017
Clinical Research Facility
mi
from
Newport Beach, CA
Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Status: Enrolling
Updated: 9/4/2017
Clinical Research Facility
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Status: Enrolling
Updated:  9/4/2017
Clinical Research Facility
mi
from
San Diego, CA
Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Status: Enrolling
Updated: 9/4/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Status: Enrolling
Updated:  9/4/2017
Clinical Research Facility
mi
from
Kissimmee, FL
Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Status: Enrolling
Updated: 9/4/2017
Clinical Research Facility
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Status: Enrolling
Updated:  9/4/2017
Clinical Research Facility
mi
from
Miami, FL
Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Status: Enrolling
Updated: 9/4/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Status: Enrolling
Updated:  9/4/2017
Clinical Research Facility
mi
from
Sarasota, FL
Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Status: Enrolling
Updated: 9/4/2017
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Status: Enrolling
Updated:  9/4/2017
Clinical Research Facility
mi
from
Tampa, FL
Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Ciprofloxacin DPI 32.5 mg BID (Twice a Day) Intermittently Administered for 28 Days on / 28 Days Off or 14 Days on / 14 Days Off Versus Placebo to Evaluate the Time to First Pulmonary Exacerbation and Frequency of Exacerbations in Subjects With Non-Cystic Fibrosis Bronchiectasis.
Status: Enrolling
Updated: 9/4/2017
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials